Dr.Rishi Mohan
A large proportion (15-40%) of routine patients managed in a general Ophthalmologist’s Clinic, pertain to complaints of OSD & its variants.
Confusions reign, associated with the DD, contributory factors, applicability of specific syndromes such as CVS, LIDE & CLIDE & masquerades. Concerns related to selection of lubricants, roles of adjuncts such as immune-modulators & the newer molecules (eg chloroquine & rebamipide) shall be addressed, complete with an update on existing protocols. Changing Paradigms of OHHQ & role of Vit D3 shall be discussed.
This IC has been largely re-designed from last year’s highly successful IC with the inclusion of new topics and revised content to reflect the changes in our understanding and management of OSD.
TOPICS – What is it – allergy, infection or dryness, Conventional Management Pearls, OSD Masquerades, Hyperosmolarity & Osmoprotection, MGD, OHHQ (Ocular Homeostasis & Hydration Quotient), topical Chloroquine, Cyclosporin A, Rebamipide, Role of Vit D3
| 1 | INTRODUCTION (2 mins) | Dr.Rishi Mohan | watch video |
| 2 | What’s troubling your patient – allergy, infection or dryness? (7 mins) | Dr.Quresh B Maskati | watch video |
| 3 | Conventional Management Pearls – choosing appropriate Artificial Tear drops (7 mins) | Prof.Vanathi M | watch video |
| 4 | OSD Masquerades – knowing when not to lose the way (7 mins) | Dr.Umang Mathur | watch video |
| 5 | Hyperosmolarity & Osmoprotection – Myth or Reality? (7 mins) | Dr.Rishi Mohan | watch video |
| 6 | Meibomian Gland Dysfunction – missed entity? (7 mins) | Dr.Umang Mathur | watch video |
| 7 | OHHQ – a new Paradigm; Topical Chloroquin – current understanding (7 mins) | Dr.Rajesh Sinha | watch video |
| 8 | Cyclosporin in OSD – is it worth its salt? (4 mins) | Prof.Vanathi M | watch video |
| 10 | Rebamipide – the new kid on the block (4 mins) | Dr.Quresh B Maskati | watch video |
| 11 | The inflammation connexion – Role of Vit D3 (7 mins) | Dr.Rohit Shetty | |
| 11 | Keynote Address by : Therapeutic useof Scleral Contact Lenses (10 mins) | Dr. MARK ROSENBLATT | watch video |
| Panel Discussion : (11 mins.) |
Leave a Comment